Savant Capital LLC Decreases Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Savant Capital LLC lessened its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 4.9% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 8,293 shares of the company’s stock after selling 424 shares during the period. Savant Capital LLC’s holdings in GE HealthCare Technologies were worth $641,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. WealthTrust Axiom LLC boosted its position in GE HealthCare Technologies by 5.1% in the 4th quarter. WealthTrust Axiom LLC now owns 4,027 shares of the company’s stock valued at $311,000 after buying an additional 194 shares during the period. Van ECK Associates Corp purchased a new position in GE HealthCare Technologies in the 4th quarter valued at approximately $4,475,000. Skylands Capital LLC boosted its position in GE HealthCare Technologies by 22.7% in the 4th quarter. Skylands Capital LLC now owns 112,050 shares of the company’s stock valued at $8,664,000 after buying an additional 20,725 shares during the period. Choreo LLC raised its holdings in shares of GE HealthCare Technologies by 11.8% in the 4th quarter. Choreo LLC now owns 3,647 shares of the company’s stock valued at $282,000 after purchasing an additional 384 shares in the last quarter. Finally, Sector Gamma AS raised its holdings in shares of GE HealthCare Technologies by 7.8% in the 4th quarter. Sector Gamma AS now owns 247,531 shares of the company’s stock valued at $19,139,000 after purchasing an additional 17,942 shares in the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

Insiders Place Their Bets

In other GE HealthCare Technologies news, insider Frank R. Jimenez acquired 1,315 shares of the stock in a transaction on Wednesday, May 1st. The shares were bought at an average cost of $76.52 per share, with a total value of $100,623.80. Following the transaction, the insider now owns 75,796 shares of the company’s stock, valued at approximately $5,799,909.92. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 0.27% of the stock is currently owned by insiders.

GE HealthCare Technologies Price Performance

Shares of NASDAQ:GEHC opened at $79.47 on Friday. The company’s fifty day moving average price is $88.25 and its 200 day moving average price is $78.89. GE HealthCare Technologies Inc. has a 12 month low of $62.35 and a 12 month high of $94.50. The company has a debt-to-equity ratio of 1.11, a current ratio of 1.06 and a quick ratio of 0.83. The firm has a market capitalization of $36.27 billion, a P/E ratio of 23.24, a P/E/G ratio of 2.86 and a beta of 1.26.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings results on Tuesday, April 30th. The company reported $0.90 EPS for the quarter, hitting the consensus estimate of $0.90. GE HealthCare Technologies had a net margin of 8.05% and a return on equity of 25.32%. The firm had revenue of $4.65 billion for the quarter, compared to analyst estimates of $4.80 billion. During the same period last year, the business earned $0.85 EPS. GE HealthCare Technologies’s revenue for the quarter was down 1.2% compared to the same quarter last year. As a group, sell-side analysts predict that GE HealthCare Technologies Inc. will post 4.27 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th will be given a dividend of $0.03 per share. This represents a $0.12 annualized dividend and a yield of 0.15%. The ex-dividend date is Thursday, April 18th. GE HealthCare Technologies’s payout ratio is currently 3.51%.

Analyst Ratings Changes

A number of brokerages have recently weighed in on GEHC. HSBC began coverage on shares of GE HealthCare Technologies in a report on Thursday, February 15th. They issued a “buy” rating and a $100.00 price objective on the stock. Bank of America reduced their price objective on shares of GE HealthCare Technologies from $94.00 to $86.00 and set a “neutral” rating on the stock in a report on Wednesday. UBS Group upgraded shares of GE HealthCare Technologies from a “sell” rating to a “neutral” rating and raised their price objective for the company from $66.00 to $88.00 in a report on Monday, February 12th. Argus raised their price objective on shares of GE HealthCare Technologies from $80.00 to $110.00 and gave the company a “buy” rating in a report on Monday, April 1st. Finally, Citigroup raised their price objective on shares of GE HealthCare Technologies from $88.00 to $103.00 and gave the company a “buy” rating in a report on Wednesday, April 3rd. Four investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $95.00.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.